AT-1501
AT-1501-K102
Phase 2 small_molecule active
Quick answer
AT-1501 for Prevention of Rejection in Kidney Transplant is a Phase 2 program (small_molecule) at Eledon Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Eledon Pharmaceuticals
- Indication
- Prevention of Rejection in Kidney Transplant
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active